Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1983 1
1984 1
1986 4
1987 4
1988 9
1989 8
1990 2
1991 1
1992 3
1993 2
1994 2
1995 6
1996 3
1997 7
1998 3
1999 4
2000 2
2001 2
2002 1
2003 3
2004 3
2005 10
2006 6
2007 5
2008 3
2009 1
2010 2
2011 2
2012 2
2013 2
2015 2
2016 12
2017 4
2018 4
2019 6
2020 17
2021 17
2022 12
2023 9
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

176 results

Results by year

Filters applied: . Clear all
Page 1
Effectiveness and safety of anti-IL-5/Rα biologics in eosinophilic granulomatosis with polyangiitis: a two-year multicenter observational study.
Nolasco S, Portacci A, Campisi R, Buonamico E, Pelaia C, Benfante A, Triggiani M, Spadaro G, Caiaffa MF, Scioscia G, Detoraki A, Valenti G, Papia F, Tomasello A, Crimi N, Scichilone N, Pelaia G, Carpagnano GE, Crimi C. Nolasco S, et al. Among authors: crimi n. Front Immunol. 2023 Jun 30;14:1204444. doi: 10.3389/fimmu.2023.1204444. eCollection 2023. Front Immunol. 2023. PMID: 37457743 Free PMC article.
Real-world characteristics of "super-responders" to mepolizumab and benralizumab in severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis.
Portacci A, Campisi R, Buonamico E, Nolasco S, Pelaia C, Crimi N, Benfante A, Triggiani M, Spadaro G, Caiaffa MF, Scioscia G, Detoraki A, Valenti G, Papia F, Tomasello A, Scichilone N, Pelaia G, Crimi C, Carpagnano GE. Portacci A, et al. Among authors: crimi n. ERJ Open Res. 2023 Oct 30;9(5):00419-2023. doi: 10.1183/23120541.00419-2023. eCollection 2023 Sep. ERJ Open Res. 2023. PMID: 37908397 Free PMC article.
Bronchiectasis and asthma: a dangerous liaison?
Crimi C, Ferri S, Crimi N. Crimi C, et al. Among authors: crimi n. Curr Opin Allergy Clin Immunol. 2019 Feb;19(1):46-52. doi: 10.1097/ACI.0000000000000492. Curr Opin Allergy Clin Immunol. 2019. PMID: 30516546 Review.
Benralizumab Effectiveness in Severe Eosinophilic Asthma with Co-Presence of Bronchiectasis: A Real-World Multicentre Observational Study.
Campisi R, Nolasco S, Pelaia C, Impellizzeri P, D'Amato M, Portacci A, Ricciardi L, Scioscia G, Crimi N, Scichilone N, Foschino Barbaro MP, Pelaia G, Carpagnano GE, Vatrella A, Crimi C; Southern Italy Network on Severe Asthma Therapy. Campisi R, et al. Among authors: crimi n. J Clin Med. 2023 Jun 9;12(12):3953. doi: 10.3390/jcm12123953. J Clin Med. 2023. PMID: 37373648 Free PMC article.
Asthma control and bronchodilator response.
Heffler E, Crimi N. Heffler E, et al. Among authors: crimi n. Respir Med. 2016 Jul;116:109. doi: 10.1016/j.rmed.2016.05.013. Epub 2016 May 15. Respir Med. 2016. PMID: 27211114 Free article. No abstract available.
Omalizumab Treatment of Vernal Keratoconjunctivitis.
Heffler E, Picardi G, Liuzzo MT, Pistorio MP, Crimi N. Heffler E, et al. Among authors: crimi n. JAMA Ophthalmol. 2016 Apr;134(4):461-3. doi: 10.1001/jamaophthalmol.2015.5679. JAMA Ophthalmol. 2016. PMID: 26795360 No abstract available.
Omalizumab for the treatment of chronic spontaneous urticaria in clinical practice.
Bongiorno MR, Crimi N, Corrao S, Allotta A, Arena A, Brusca I, Heffler E, Malara G, Milioto M, Pistone G, Porto M, Raia E, Valenti G. Bongiorno MR, et al. Among authors: crimi n. Ann Allergy Asthma Immunol. 2016 Dec;117(6):703-707. doi: 10.1016/j.anai.2016.08.006. Epub 2016 Oct 6. Ann Allergy Asthma Immunol. 2016. PMID: 27720581 Review. No abstract available.
176 results